Federal Court of Appeal Decides Case Splitting through NOAs is an Abuse of Process
Federal Court upholds PMPRB jurisdiction based on “clinical similarities”
Pharma in Brief’s 2023 Year in Review and Trends for 2024
Federal Court Notice on Use of Artificial Intelligence in Court Proceedings
New Canadian Drug Agency formed, while National Pharmacare bill is delayed into 2024
Federal Court refuses to issue injunction on infringed antibody formulation patent
Drug pricing: PMPRB releases scoping paper to consult on new Guidelines
Drug pricing: PMPRB announces framework for new guidelines consultation
Drug reimbursement: CADTH publishes procedures on time-limited reimbursement
Subscribe: Subscribe via RSS
Firm/Org